BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 842 | Download: 660
Publication Name World Journal of Immunology
Manuscript ID 4489
Country Greece
Received
2013-07-02 09:49
Peer-Review Started
2013-07-02 15:23
To Make the First Decision
2013-07-19 08:48
Return for Revision
2013-07-20 22:33
Revised
2013-07-29 22:00
Second Decision
2013-09-13 15:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-13 22:53
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-10-29 16:59
Publish the Manuscript Online
2013-11-29 02:07
ISSN 2219-2824 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Minireviews
Article Title Decoy receptor 3: Its role as biomarker for chronic inflammatory diseases
Manuscript Source Invited Manuscript
All Author List Spyros I Siakavellas and Giorgos Bamias
Funding Agency and Grant Number
Corresponding Author Giorgos Bamias, MD, Academic Department of Gastroenterology, Ethnikon and Kapodistriakon University, Laikon Hospital, 17 Agiou Thoma Str., 11527 Athens, Greece. gbamias@gmail.com
Key Words Decoy receptor 3; Tumor necrosis factor receptor superfamily of proteins; Chronic inflammation; Infection; Disease activity; Biomarker
Core Tip Members of the tumor-necrosis factor-? (TNF-?) and TNF-? receptor superfamilies play important roles in the function of the immune system. Decoy receptor 3 (DcR3) is a decoy receptor that exists only as soluble protein and has the ability to bind to FasL, LIGHT and TL1A. Recent studies showed that DcR3 is upregulated and may be pathogenetically implicated in systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease and infection. DcR3 may become a useful biomarker for chronic inflammatory disorders, as it is upregulated in response to inflammatory stimuli, and may serve both as a prognostic factor for disease severity and as an indicator of response to treatment.
Publish Date 2013-11-29 02:07
Citation Siakavellas SI, Bamias G. Decoy receptor 3: Its role as biomarker for chronic inflammatory diseases. World J Immunol 2013; 3(3): 44-53
URL http://www.wjgnet.com/2219-2824/full/v3/i3/44.htm
DOI http://dx.doi.org/10.5411/wji.v3.i3.44
Full Article (PDF) WJI-3-44.pdf
Manuscript File 4489-Review.docx
Answering Reviewers 4489-Answering reviewers.pdf
Copyright License Agreement 4489-Copyright assignment.docx
Peer-review Report 4489-Peer reviewer(s).pdf
Scientific Editor Work List 4489-Scientific editor work list.doc